The predictive validity of atypical neurovegetative depressive symptoms identified by the first principal component in the DUAG trial of moclobemide versus clomipramine

P Bech; K B Stage; J K Larsen; P Vestergaard; L F Gram; Danish University Antidepressant Group (DUAG*)

doi:10.1016/j.jad.2012.02.011

The predictive validity of atypical neurovegetative depressive symptoms identified by the first principal component in the DUAG trial of moclobemide versus clomipramine

P Bech
, K B Stage
, J K Larsen
, P Vestergaard
, L F Gram
, Danish University Antidepressant Group (DUAG*)

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Abstract

To investigate to what extent the primary depression subtype atypical depression can predict differential outcome of the mono-amino-oxidase inhibitor (MAO-I) moclobemide and the tricyclic antidepressant clomipramine in the Danish University Antidepressant Group Study (DUAG).

Originalsprog	Engelsk
Tidsskrift	Journal of Affective Disorders
Vol/bind	140
Udgave nummer	3
Sider (fra-til)	253-9
Antal sider	7
ISSN	0165-0327
DOI	https://doi.org/10.1016/j.jad.2012.02.011
Status	Udgivet - 2012

Dokumenter og links

10.1016/j.jad.2012.02.011

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

Bech, P., Stage, K. B., Larsen, J. K., Vestergaard, P., Gram, L. F., & Danish University Antidepressant Group (DUAG*) (2012). The predictive validity of atypical neurovegetative depressive symptoms identified by the first principal component in the DUAG trial of moclobemide versus clomipramine. Journal of Affective Disorders, 140(3), 253-9. https://doi.org/10.1016/j.jad.2012.02.011

@article{3896dc98acf8423e878b1ff214a23673,

title = "The predictive validity of atypical neurovegetative depressive symptoms identified by the first principal component in the DUAG trial of moclobemide versus clomipramine",

abstract = "To investigate to what extent the primary depression subtype atypical depression can predict differential outcome of the mono-amino-oxidase inhibitor (MAO-I) moclobemide and the tricyclic antidepressant clomipramine in the Danish University Antidepressant Group Study (DUAG).",

keywords = "Antidepressive Agents, Tricyclic, Clomipramine, Depressive Disorder, Major, Double-Blind Method, Female, Humans, Male, Moclobemide, Monoamine Oxidase Inhibitors, Principal Component Analysis",

author = "P Bech and Stage, \{K B\} and Larsen, \{J K\} and P Vestergaard and Gram, \{L F\} and \{Danish University Antidepressant Group (DUAG*)\}",

year = "2012",

doi = "10.1016/j.jad.2012.02.011",

language = "English",

volume = "140",

pages = "253--9",

journal = "Journal of Affective Disorders",

issn = "0165-0327",

publisher = "Elsevier",

number = "3",

}

Bech, P, Stage, KB, Larsen, JK, Vestergaard, P, Gram, LF & Danish University Antidepressant Group (DUAG*) 2012, 'The predictive validity of atypical neurovegetative depressive symptoms identified by the first principal component in the DUAG trial of moclobemide versus clomipramine', Journal of Affective Disorders, bind 140, nr. 3, s. 253-9. https://doi.org/10.1016/j.jad.2012.02.011

TY - JOUR

T1 - The predictive validity of atypical neurovegetative depressive symptoms identified by the first principal component in the DUAG trial of moclobemide versus clomipramine

AU - Bech, P

AU - Stage, K B

AU - Larsen, J K

AU - Vestergaard, P

AU - Gram, L F

AU - Danish University Antidepressant Group (DUAG)

PY - 2012

Y1 - 2012

N2 - To investigate to what extent the primary depression subtype atypical depression can predict differential outcome of the mono-amino-oxidase inhibitor (MAO-I) moclobemide and the tricyclic antidepressant clomipramine in the Danish University Antidepressant Group Study (DUAG).

AB - To investigate to what extent the primary depression subtype atypical depression can predict differential outcome of the mono-amino-oxidase inhibitor (MAO-I) moclobemide and the tricyclic antidepressant clomipramine in the Danish University Antidepressant Group Study (DUAG).

KW - Antidepressive Agents, Tricyclic

KW - Clomipramine

KW - Depressive Disorder, Major

KW - Double-Blind Method

KW - Female

KW - Humans

KW - Male

KW - Moclobemide

KW - Monoamine Oxidase Inhibitors

KW - Principal Component Analysis

U2 - 10.1016/j.jad.2012.02.011

DO - 10.1016/j.jad.2012.02.011

M3 - Journal article

C2 - 22381949

SN - 0165-0327

VL - 140

SP - 253

EP - 259

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

IS - 3

ER -

The predictive validity of atypical neurovegetative depressive symptoms identified by the first principal component in the DUAG trial of moclobemide versus clomipramine

Abstract

Dokumenter og links

SDU link

Fingeraftryk

Citationsformater